CLINICAL_TRIALS
trial_result
· 2019-06-25
Clinical Trial Update: Intranasal Oxytocin for Infants With Prader-Willi Syndrome [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating intranasal oxytocin in infants with Prader-Willi syndrome has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Florida | Conditions: Prader-Willi Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-25